{"prediction": {"id": "16a9507c-e6c9-5fca-9e84-1c6ee1fae57b", "work_id": "351361bc-3e10-51b4-ac51-aa2e9d9e12f8", "study_id": "f93ed617-3d3f-5b3f-9900-fd41a6aebb53", "kind": "Model evaluation", "pages": [11], "version": "Version of record", "source_work_id": "351361bc-3e10-51b4-ac51-aa2e9d9e12f8", "title": "Structure-based virtual screening identifies ethyl rosmarinate as a SLC1A6-targeted therapeutic candidate for bladder cancer.", "doi": "10.3389/fphar.2026.1895264", "pdf_sha256": "dd889a542d4ba2fc96e2785b850e69399719f1f12445481e07e78d23ad506637", "physical_page_count": 26}, "fields": {"endpoint": {"value": "hazard_ratio", "source_basis": "verified_profile", "pages": [11]}, "family": {"value": "clinical_outcomes", "source_basis": "verified_profile", "pages": [11]}, "measured_variable": {"value": "survival_overall", "source_basis": "original_pdf_review", "pages": [11, 12]}, "metric": {"value": "hazard_ratio", "source_basis": "original_pdf_review", "pages": [11]}, "outcome_target": {"value": "overall_survival", "source_basis": "original_pdf_review", "pages": [11]}, "prediction_target_type": {"value": "future_clinical_outcome", "source_basis": "original_pdf_review", "pages": [11]}, "result_operation": {"value": "survival_association", "source_basis": "original_pdf_review", "pages": [11]}}, "endpoints": [{"term": "risk_estimate", "label": "Risk and probability estimates"}, {"term": "statistical_test", "label": "Statistical test outcomes"}, {"term": "survival", "label": "Survival and mortality"}], "validations": [{"id": "16fd32a9-bda8-53f7-892d-fabe0df81982", "claim_id": "16a9507c-e6c9-5fca-9e84-1c6ee1fae57b", "coverage": "direct_comparison", "support": "indeterminate", "source": "same_source", "overlap": "overlap", "comparability": "matched", "statistics": "non_significant", "anchors": [{"work_id": "351361bc-3e10-51b4-ac51-aa2e9d9e12f8", "version": "Version of record", "pages": [11, 12]}]}], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}